The US Food and Drug Administration (FDA) has cleared BellaMia Technologies, Inc.’s Botticelli laser platform for marketing.
The Botticelli is an all-in-one system for skin rejuvenation that incorporates multiple lasers.
“We must use many devices to deliver all the treatments that our patients request. The Botticelli provides a single solution that can address most skin conditions of our patients,” says Head of the Scientific Advisory Board Jill Waibel, MD, in a news release. She is also a Dermatologist in Miami, FL.
